AVITA Medical Inc. (RCEL)

10.26

0.19 (1.89%)

At close: Apr 28, 2025, 3:59 PM

9.73

-5.17%

After-hours: Apr 28, 2025, 05:38 PM EDT

AVITA Medical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019
Revenue	58.88M	51.87M	46.29M	45.82M	45.91M	38.71M	36.94M	38.41M	35.48M	35.53M	30.84M	25.61M	23.63M	21.38M	15.76M	9.46M	4.82M
Cost of Revenue	11.07M	10.17M	8.87M	8.75M	7.9M	6.6M	6.64M	7.09M	7.03M	7.24M	6.45M	4.66M	4.8M	4.42M	3.15M	2.12M	917.11K
Gross Profit	57.47M	51.36M	47.09M	41.5M	38.01M	32.12M	30.3M	31.32M	28.45M	28.29M	24.39M	20.95M	18.83M	16.96M	12.61M	7.34M	3.9M
Operating Income	-54.61M	-49.25M	-41.7M	-39.56M	-42.48M	-39.45M	-34.94M	-30.15M	-25.84M	-34.16M	-48.33M	-65.49M	-73.28M	-64.44M	-45.57M	-20.52M	-5.42M
Interest Income	40.86K	34.69K	29.97K	36.44K	38.64K	29.26K	23.46K	14.96K	7.84K	17.62K	29.21K	33.39K	42.33K	48.85K	37.25K	29.12K	16.3K
Pretax Income	-50.68M	-45.88M	-39.37M	-38.26M	-42.08M	-39.29M	-34.94M	-30.18M	-25.84M	-34.17M	-48.16M	-64.75M	-72.41M	-63.43M	-44.72M	-20.25M	-5.28M
Net Income	-50.8M	-45.98M	-39.46M	-38.31M	-42.12M	-39.33M	-34.98M	-30.23M	-25.88M	-34.21M	-48.21M	-64.78M	-72.43M	-63.43M	-44.72M	-20.25M	-5.28M
Selling & General & Admin	89.37M	79.87M	71.25M	65.58M	62.98M	55.57M	49.34M	44.76M	39.31M	46.6M	57.42M	73.39M	80.09M	73.87M	53.63M	25.72M	9.93M
Research & Development	26.28M	25.38M	22.19M	20.17M	20.99M	18.43M	17.98M	18.55M	17.13M	18.46M	18.16M	16.81M	15.74M	13.45M	9.77M	5.72M	2.42M
Other Expenses	n/a	n/a	n/a	n/a	n/a	16K	18K	18K	18K	2K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	108.11M	97.2M	86.42M	79.72M	80.05M	71.38M	65.22M	61.48M	54.28M	62.43M	72.52M	85.66M	91.21M	80.34M	57.29M	27.56M	9.17M
Interest Expense	n/a	n/a	n/a	n/a	n/a	9K	18K	18K	18K	9K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	50.5M	42.58M	35.28M	31.95M	29.45M	24.51M	20.93M	19.29M	17.14M	18.18M	20.21M	22.52M	23.51M	23.34M	17.16M	10.05M	4.39M
Cost & Expenses	119.18M	107.37M	95.29M	88.48M	87.95M	77.98M	71.86M	68.57M	61.31M	69.67M	78.98M	90.32M	96.01M	84.76M	60.45M	29.68M	10.08M
Income Tax Expense	116.76K	105.9K	92.17K	52.65K	43.54K	43.29K	44.49K	52.31K	40.43K	48.4K	47.2K	34.03K	19.76K	5.8K	n/a	n/a	n/a
Shares Outstanding (Basic)	25.4M	25.24M	25.2M	25.08M	25.01M	24.97M	24.94M	24.93M	24.91M	24.86M	22.73M	21.62M	21.31M	21.37M	21.19M	19.82M	18.72M
Shares Outstanding (Diluted)	25.4M	25.24M	25.2M	25.08M	25.01M	24.97M	24.94M	24.93M	24.91M	24.86M	22.73M	21.62M	21.5M	21.37M	21.22M	19.88M	18.72M
EPS (Basic)	-2.01	-1.83	-1.57	-1.53	-1.69	-1.58	-1.41	-1.25	-1.12	-1.54	-2.23	-3.03	-3.44	-3.06	-2.18	-1.03	-0.28
EPS (Diluted)	-2.01	-1.83	-1.57	-1.53	-1.69	-1.58	-1.41	-1.25	-1.12	-1.55	-2.24	-3.04	-3.46	-3.07	-2.19	-1.04	-0.28
EBITDA	-53.74M	-48.42M	-40.9M	-38.73M	-41.64M	-38.8M	-34.48M	-29.69M	-25.4M	-33.43M	-47.3M	-64.54M	-72.4M	-63.75M	-45.18M	-20.28M	-5.32M
EBIT	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Depreciation & Amortization	1.89M	2.03M	2.13M	1.3M	604K	470K	399K	538K	678K	715K	661K	857K	794K	649K	528K	165K	66K